Contracts and Grants

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member’s name and school(s) appointments at The University of Texas Health Science Center at Houston, project title, contracting or granting agency, and funding amount.

New

Jeffrey K. Actor, Medical School (MS) and Graduate School of Biomedical Sciences (GSBS), Immunomodulation of Sepsis, Cyto Genix Inc., $30,366.

Ananth Annapragada, School of Health Information Sciences (SHIS) and GSBS, A Novel Multiple Ligand Strategy for Targeting Tumors, Georgia Institute of Technology, $26,600.

Noriaki Aoki, SHIS, Data Mining to Identify the Risk Factors of the Health Behavior Related Disease and Clinical and Economical Evalaution of the Improvement of These Factors, Schull Institute, $34,380.

Ben J. Barnett, MS, A Randomized, Double-Blind, Controlled Dose Finding Study of NGX-4010 for the Treatment of Painful HIV-Associated Distal Symmetrical Polyneuropathy, Neurogesx Inc, $40,040.

Elmer V. Bernstam, SHIS and MS, Using Citation Data to Improve Retrieval from Medline, National Institutes of Health (NIH), National Library of Medicine, $486,000.

Diane L. Bick, MS, The Role of Cardiolipin in Apoptosis, NIH, National Heart, Lung and Blood Institute (NHLBI), $1,039,500.

Staley Brod, MS, Phase IV Study REBIF Compared to Copaxone, Serono Inc., $53,177.

Thomas O. Clanton, MS, Strength of the Achilles Insertion Site After Partial Retrocalcaneal Exostectomy: A Biomechanical Study, American Orthopaedic Foot and Ankle Society, $10,000.

Mazen M. Dimachkie, MS, Clinical Service Agreement with Spine Associates of Houston LLC, Spine Associates of Houston LLC, $42,000.

Peter A. Doris, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM) and GSBS, Transcriptional Regulation of Renal Injury in Hypertension, American Heart Association, Texas, $124,000.

Keith Hoots, MS, Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (RAHF-PFM): Evaluation of Immunogenicity, Efficacy and Safety in Previously Untreated Patients with Hemophilia, Baxter Health Care Corporation, $60,168.

Lillian S. Kao, MS, Studies on Hyperglycemia in Surgical Infection, Surgical Infection Society Foundation, $40,000.

Frederick A. Moore,MS, A Phase III, Randomized, Controlled, Open-Label, Multicenter, Parallel Group Study Using Provisions for Exception from Informed Consent Requirements Designed to Evaluate the Saety and Efficacy of Poly SFH-P Injection (Polymerized Human Hemoglobin (Pyridoxylated), Polyheme when Used to Treat Patients in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Prehospital Setting, Northfield Laboratories Inc., $288,000.

John M. Powers, Dental Branch (DB) and GSBS, Properties of New Cements and Liners, Cooley & Cooley Ltd., $500; and Effect of Cements/Alloys on Bond Strength of Cast Post, Pentron Laboratory Technologies LLC, $2,400.

Blanca I. Restrepo, School of Public Health (SPH) and GSBS, Tuberculosis Elimination, Texas Department of Health, $25,109.

Ann-Bin Shyu, MS and GSBS, Cytokine and Chemokine mRNA Turnover and Airway Inflammation, Sandler Family Supporting Foundation, $750,000.

William D. Spears, SPH, Project SEEK, Center for Health Care Services, $23,429.

Paul R. Swank, MS, Early Reading First Evaluation, Decision Information Resources Inc., $170,745.

Patrick M. Tarwater, SPH, Immunophilin Ligands for HIV Dementia and Neuropathy, Johns Hopkins University, $5,808; CNS and Peripheral Viral Reservoirs in a SIV Model of HIV HAART, Johns Hopkins University, $15,053; and Neuroprotective Effects of Minocycline in Lentiviral Infection, Johns Hopkins University, $5,769.

Martin E. Young, IMM and GSBS, Molecular Circadian Clock Within the Heart , NIH, NHLBI, $1,438,925.

Renewal

Noriaki Aoki, SHIS,Web-Based Patient Registry Development for Qualtiy Assessment of the Care for Trauma, AMI and Stroke in the Emergency Centers in Japan, Schull Institute, $42,772; and Development and Technology Assessment, Using Both Qualitative and Quantitative Approaches, of a Handheld Based Care Support System for Patients with Type 1 Diabetes Mellitus in Japan, Schull Institute, $21,907.

Douglas A. Baxter, MS and GSBS, Computational Models of Adaptive Neural Circuits, National Institutes of Health, National Center for Research Resources, $664,352.

Bryant Boutwell, MS, CATCHEM Project, University of Texas Medical Branch at Galveston, $3,240.

Gloria P. Heresi, MS, Medical Case Management Team Targeted to African-American Women and Children, Harris County, $251,454; and Community-Based Primary Care Targeted to Pediatric Patients, Harris County, $48,444.

James J. Knierim, MS and GSBS, Multi-Site Analysis of Hippocampal Neuronal Ensembles, NIH, National Institute of Neurological Disorders and Stroke, $1,098,900.

John M. Powers, DB and GSBS, In Vitro Properties of Dental Materials, Dental Consultants Inc., $24,400.

Transfer

Xianglin L. Du, SPH, Evaluation of Chemotherapy Claims for Breast Cancer, NIH, National Cancer Institute, $193,867.